These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38898405

  • 21. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients.
    Mohamed AA, Esmail OE, Ibrahim AMA, Makled S, Al-Hussain E, Elsaid A, Alboraie M, El-Awady RR.
    J Med Virol; 2023 Jan; 95(1):e28343. PubMed ID: 36424348
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
    Alsalawy NF, Darwish RK, Kamal MM, ElTaweel AE, Shousha HI, Elbaz TM.
    J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
    [Abstract] [Full Text] [Related]

  • 23. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS, Wahab EA, Elhady HA, Elgerby MM.
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [Abstract] [Full Text] [Related]

  • 24. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK, Shaker OG, Ismail MF, Sayed NH.
    Gene; 2013 Sep 25; 527(2):516-20. PubMed ID: 23845776
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C, Scapaticci M, Nedovic B, Annicchiarico EB, Guarino D, Leoncini E, Boccia S, Gasbarrini A, Capoluongo E.
    Int J Biol Markers; 2017 May 04; 32(2):e190-e194. PubMed ID: 28058700
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
    Deng Y, Chen ZJ, Lan F, He QT, Chen SY, Du YF, Li S, Qin X.
    J Clin Lab Anal; 2019 Oct 04; 33(8):e22977. PubMed ID: 31301090
    [Abstract] [Full Text] [Related]

  • 31. Association study of c.910A>G and c.1686C>G polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in the Chinese population.
    Xia WF, Ma XP, Li XR, Dong H, Yi JL.
    Genet Mol Res; 2014 Feb 28; 13(1):1314-22. PubMed ID: 24634229
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
    Marangon CG, de Bitencorte JT, Michita RT, Lunge VR, Dos Santos DC, Álvares-da-Silva MR, Simon D.
    Pathol Oncol Res; 2020 Jul 28; 26(3):1519-1525. PubMed ID: 31471884
    [Abstract] [Full Text] [Related]

  • 35. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N, Najafi-Ghobadi K, Abbaszadeh H.
    Cancer Rep (Hoboken); 2023 Mar 28; 6(3):e1776. PubMed ID: 36573562
    [Abstract] [Full Text] [Related]

  • 36. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
    De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, Crovatto M, Buonadonna A, Tiribelli C, Toffoli G.
    World J Gastroenterol; 2017 Sep 28; 23(36):6674-6684. PubMed ID: 29085212
    [Abstract] [Full Text] [Related]

  • 37. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
    Bose S, Tripathi DM, Sukriti, Sakhuja P, Kazim SN, Sarin SK.
    Gene; 2013 May 01; 519(2):231-7. PubMed ID: 23454624
    [Abstract] [Full Text] [Related]

  • 38. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, Shimada N, Komori A, Toyoda H, Kumada T, Namisaki T, Yoshiji H, Sakamoto N, Nakagawa M, Asahina Y, Kurosaki M, Izumi N, Enomoto N, Kusakabe A, Kajiwara E, Itoh Y, Ide T, Tamori A, Matsubara M, Kawada N, Shirabe K, Tomita E, Honda M, Kaneko S, Nishina S, Suetsugu A, Hiasa Y, Watanabe H, Genda T, Sakaida I, Nishiguchi S, Takaguchi K, Tanaka E, Sugihara J, Shimada M, Kondo Y, Kawai Y, Kojima K, Nagasaki M, Tokunaga K, Tanaka Y, Japanese Genome-Wide Association Study Group for Viral Hepatitis.
    Gastroenterology; 2017 May 01; 152(6):1383-1394. PubMed ID: 28163062
    [Abstract] [Full Text] [Related]

  • 39. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D, Jiang H, Gu Q, Zhang D, Li Z.
    Tumour Biol; 2013 Oct 01; 34(5):3265-9. PubMed ID: 23780894
    [Abstract] [Full Text] [Related]

  • 40. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study.
    Abdel Ghafar MT, El-Rashidy MA, Gharib F, Al-Ashmawy GM.
    Environ Mol Mutagen; 2021 Aug 01; 62(7):399-408. PubMed ID: 34331480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.